Citigroup Inc Vertex Pharmaceuticals Inc Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Citigroup Inc holds 479,607 shares of VRTX stock, worth $241 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

479,607

Previous 399,768 19.97%

Holding current value

$241 Million

Previous $167 Million 34.53%

% of portfolio

0.15%

Previous 0.11%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$392.81 - $485.53 $31.4 Million - $38.8 Million	79,839 Added 19.97%	479,607 $225 Million
Q1 2024 May 10, 2024	SELL	$407.69 - $446.08 $22.4 Million - $24.5 Million	-54,824 Reduced 12.06%	399,768 $167 Million
Q4 2023 Feb 09, 2024	BUY	$343.0 - $410.68 $3.09 Million - $3.69 Million	8,995 Added 2.02%	454,592 $185 Million
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $5.88 Million - $6.31 Million	-17,399 Reduced 3.76%	445,597 $155 Million
Q2 2023 Aug 10, 2023	BUY	$314.42 - $351.91 $12 Million - $13.4 Million	38,119 Added 8.97%	462,996 $163 Million
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $16.9 Million - $19.3 Million	-59,620 Reduced 12.31%	424,877 $134 Million
Q4 2022 Feb 09, 2023	BUY	$285.76 - $321.48 $358,914 - $403,778	1,256 Added 0.26%	484,497 $140 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $99,947 - $111,518	365 Added 0.08%	483,241 $140 Million
Q2 2022 Aug 10, 2022	SELL	$234.96 - $292.55 $8.26 Million - $10.3 Million	-35,160 Reduced 6.79%	482,876 $136 Million
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $31.3 Million - $36.9 Million	-141,335 Reduced 21.43%	518,036 $135 Million
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $14.1 Million - $17.8 Million	79,762 Added 13.76%	659,371 $145 Million
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $105 Million - $118 Million	579,609 New	579,609 $105 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account